Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2024-07-22
TNGXTango Therapeutics, Inc.Third Rock Ventures Iv, L.P.10%S - Sale$9.78-387,74018,072,074-2%-$3,793,446
2024-07-22
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaCEO, PresS - Sale$497.00-15,202106,172-13%-$7,555,394
2024-07-22
RCKTRocket Pharmaceuticals, Inc.Militello JohnSee RemarksS - Sale$23.02-81252,515-2%-$18,688
2024-07-23
GLSIGreenwich Lifesciences, Inc.Patel SnehalCEO, CFO, 10%P - Purchase$15.89+1,5005,527,1020%+$23,835
M
2024-07-22
VRCAVerrica Pharmaceuticals Inc.White TedPres, CEOS - Sale$7.06-32,623249,967-12%-$230,306
M
2024-07-22
VRCAVerrica Pharmaceuticals Inc.Bonaccorso JoeChief Commercial OfficerS - Sale$7.06-25,576106,816-19%-$180,557
M
2024-07-22
VRCAVerrica Pharmaceuticals Inc.Goldenberg GaryChief Medical OfficerS - Sale$7.06-18,507107,750-15%-$130,653
M
2024-07-22
VRCAVerrica Pharmaceuticals Inc.Hayes Christopher G.GCS - Sale$7.06-21,740141,486-13%-$153,477
M
2024-07-19
WGSGenedx Holdings Corp.Opko Health, Inc.10%S - Sale$32.98-150,0003,258,403-4%-$4,946,935
M
2024-07-19
ELYMEliem Therapeutics, Inc.Morisset ValerieEVP, R, D, CSOS - Sale$7.65-129,20631,317-80%-$988,495
D
2024-07-23
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale+OE$57.02-7,300129,004-5%-$416,246
DM
2024-07-19
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$330.45-7,200646,231-1%-$2,379,244
D
2024-07-19
RNAAvidity Biosciences, Inc.Levin Arthur ADirS - Sale+OE$45.01-5,000168,702-3%-$225,069
2024-07-19
SGMTSagimet Biosciences Inc.Martins Eduardo BrunoChief Medical OfficerS - Sale$3.10-8,35781,213-9%-$25,910
2024-07-19
SGMTSagimet Biosciences Inc.Rozek ElizabethGC, CCOS - Sale$3.10-10,914160,506-6%-$33,830
2024-07-19
SGMTSagimet Biosciences Inc.Kemble GeorgeExec COBS - Sale$3.10-14,062142,318-9%-$43,605
2024-07-23
DERMJourney Medical CorpBenesch JosephCFOS - Sale$5.40-4,05556,655-7%-$21,897
A
2024-07-22
GALTGalectin Therapeutics IncEldred KaryDirP - Purchase$2.39+40054,138+1%+$956
2024-01-16
GALTGalectin Therapeutics IncEldred KaryDirP - Purchase$2.39+40054,138+1%+$956
2024-07-22
BSPKBespoke Extracts, Inc.Feinsod MichaelCEO, 10%P - Purchase$0.07+3,0002,148,1120%+$210
2024-07-19
LQDALiquidia CorpSaggar RajeevChief Medical OfficerS - Sale$11.13-1,873208,329-1%-$20,846
2024-07-18
TNGXTango Therapeutics, Inc.Third Rock Ventures Iv, L.P.10%S - Sale$9.81-191,49018,459,814-1%-$1,878,479
M
2024-07-18
ACRSAclaris Therapeutics, Inc.Leonard Braden Michael10%P - Purchase$1.30+154,72227,180,977+1%+$201,808
2024-07-18
GLSIGreenwich Lifesciences, Inc.Thompson JayeVP Clinical Reg AffairsP - Purchase$16.00+1,000261,3480%+$16,000
D
2024-07-18
ANABAnaptysbio, IncLizzul Paul F.Chief Medical OfficerS - Sale+OE$35.00-1,50011,618-11%-$52,500
2024-07-17
WGSGenedx Holdings Corp.Opko Health, Inc.10%S - Sale$32.93-25,0003,408,403-1%-$823,188
2024-07-17
SLRNAcelyrin, Inc.Becker Daniel J.DirS - Sale$6.86-12,9990%-$7
2024-07-17
RENBRenovaro Inc.William Anderson Wittekind10%S - Sale$1.46-16,36218,484,3100%-$23,889
2024-07-18
ANIPAni Pharmaceuticals IncShanmugam MuthusamyHEAD OF R, D, COO-NOVITIUM OPSS - Sale$62.00-2,743706,2720%-$170,066
D
2024-07-17
ABBVAbbvie Inc.Gonzalez Richard AExec COBS - Sale+OE$175.00-282,845513,099-36%-$49,497,875
DM
2024-07-17
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$332.74-7,200646,231-1%-$2,395,736
D
2024-07-18
PEPGPepgen Inc.Mellion Michelle LChief Medical OfficerS - Sale+OE$18.20-12,6250-100%-$229,804
M
2024-07-17
ELYMEliem Therapeutics, Inc.Morisset ValerieEVP, R, D, CSOS - Sale$6.93-41,783160,523-21%-$289,492
2024-07-18
BHVNBiohaven Ltd.Childs John WDirP - Purchase$35.67+28,4006,460,6440%+$1,012,983
2024-07-17
ESPREsperion Therapeutics, Inc.Warren EricChief Commercial OfficerS - Sale$2.59-108165,4780%-$279
2024-07-17
ESPREsperion Therapeutics, Inc.Foody Joanne M.Chief Medical OfficerS - Sale$2.60-917272,8620%-$2,383
D
2024-07-16
AKROAkero Therapeutics, Inc.White William RichardCFOS - Sale+OE$28.05-34,81141,791-45%-$976,274
2024-07-17
PBYIPuma Biotechnology, Inc.Nougues Maximo FCFOS - Sale$3.70-4,156162,522-2%-$15,382
2024-07-17
PBYIPuma Biotechnology, Inc.Ludwig Jeffrey JeromeChief Commercial OfficerS - Sale$3.70-2,598118,388-2%-$9,615
2024-07-17
PBYIPuma Biotechnology, Inc.Hunt Douglas MSee RemarksS - Sale$3.70-3,637133,227-3%-$13,461
2024-07-17
PBYIPuma Biotechnology, Inc.Auerbach Alan HPres, CEO, 10%S - Sale$3.70-21,9207,063,5150%-$81,128
D
2024-07-16
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerS - Sale+OE$15.00-525102,873-1%-$7,876
D
2024-07-16
RYTMRhythm Pharmaceuticals, Inc.Shulman JosephChief Technical OfficerS - Sale+OE$53.00-10,46830-100%-$554,817
2024-07-16
EQEquillium, Inc.Keyes Jason ACFOS - Sale$0.87-10,000141,633-7%-$8,700
2024-07-16
PTCTPtc Therapeutics, Inc.Gravier PierreCFOS - Sale$34.02-2,26953,531-4%-$77,200
2024-07-16
SPRYArs Pharmaceuticals, Inc.Lowenthal Richard EPres, CEO, 10%S - Sale$11.40-100,00012,365,600-1%-$1,140,295
2024-07-16
SPRYArs Pharmaceuticals, Inc.Tanimoto SarinaChief Medical Officer, 10%S - Sale$11.40-100,00012,365,600-1%-$1,140,295
2024-07-17
OPTNOptinose, Inc.Krick Anthony JChief Accounting OfficerS - Sale$1.14-6,845140,758-5%-$7,803
2024-07-17
OPTNOptinose, Inc.Marino Michael F IIIGC, Corp SecS - Sale$1.14-49,408550,464-8%-$56,325
2024-07-16
NKTXNkarta, Inc.Hager Alicia J.GCS - Sale$8.00-3,396103,819-3%-$27,168
2024-07-17
OPTNOptinose, Inc.Mahmoud Ramy ACEOS - Sale$1.14-111,4261,379,400-7%-$127,026
2024-07-17
TNGXTango Therapeutics, Inc.Third Rock Ventures Iv, L.P.10%S - Sale$9.79-550,17118,651,304-3%-$5,386,339
2024-07-18
MURAMural Oncology PlcKeson-Brookes MaikenSee RemarksS - Sale$3.41-2,15743,850-5%-$7,355
2024-07-17
ETSTEarth Science Tech, Inc.Tabraue Mario GuillermoCOOP - Purchase$0.20+10,00012,341,0230%+$2,000
M
2024-07-15
TERNTerns Pharmaceuticals, Inc.Gordon Carl LDir, 10%S - Sale$10.00-56,164755,635-7%-$561,640
M
2024-07-15
TERNTerns Pharmaceuticals, Inc.Orbimed Advisors LLCDir, 10%S - Sale$10.00-56,164755,635-7%-$561,640
DM
2024-07-15
TERNTerns Pharmaceuticals, Inc.Quigley Jill M.DirS - Sale+OE$10.00-14,76530,000-33%-$147,660
2024-07-16
MNKDMannkind CorpBinder Steven B.EVP Special ProjectsS - Sale$5.93-2,8361,100,8600%-$16,817
2024-07-16
MNKDMannkind CorpThomson DavidEVP Genl Counsel, SecretaryS - Sale$5.93-3,115857,8850%-$18,472
2024-07-15
ELVNEnliven Therapeutics, Inc.Heyman Richard A.DirS - Sale$24.80-1,270199,319-1%-$31,497
M
2024-07-15
ANIPAni Pharmaceuticals IncShanmugam MuthusamyHEAD OF R, D, COO-NOVITIUM OPSS - Sale$63.73-47,257709,015-6%-$3,011,592
2024-07-16
ELYMEliem Therapeutics, Inc.Morisset ValerieEVP, R, D, CSOS - Sale$7.13-50,000202,306-20%-$356,500
2024-07-15
ARDXArdelyx, Inc.Raab MichaelPres, CEOS - Sale$5.97-7,5001,285,827-1%-$44,768
2024-07-17
ZVRAZevra Therapeutics, Inc.Clifton R. LaduaneCFO, TreasurerP - Purchase$6.77+2,00018,469+12%+$13,540
D
2024-07-15
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.COOS - Sale+OE$55.00-27,00051,653-34%-$1,485,000
D
2024-07-15
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOS - Sale+OE$55.00-25,000111,092-18%-$1,375,000
D
2024-07-16
IONSIonis Pharmaceuticals IncKlein Joseph IIIDirS - Sale+OE$50.00-12,00016,446-42%-$600,000
D
2024-07-16
IONSIonis Pharmaceuticals IncDiaz Allene M.DirS - Sale+OE$49.49-1,63715,716-9%-$81,019
2024-07-16
DAWNDay One Biopharmaceuticals, Inc.Blackman Samuel C.HEAD OF R, DS - Sale$16.01-20,0002,121,081-1%-$320,226
2024-07-15
ANNXAnnexon, Inc.Overdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale$6.02-78494,622-1%-$4,720
2024-07-15
ANNXAnnexon, Inc.Lew JenniferEVP, CFOS - Sale$6.03-1,10486,468-1%-$6,657
2024-07-15
ANNXAnnexon, Inc.Yednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$6.02-1,10692,365-1%-$6,658
D
2024-07-15
ANABAnaptysbio, IncRenton HollingsDirS - Sale+OE$30.64-10,0001,950-84%-$306,422
2024-07-15
RENBRenovaro Inc.William Anderson Wittekind10%S - Sale$1.41-21,95418,518,6720%-$30,955
DM
2024-07-15
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$327.16-7,200646,231-1%-$2,355,544
2024-07-15
PHATPhathom Pharmaceuticals, Inc.Nabulsi AzmiCOOS - Sale$11.72-10,9011,029,700-1%-$127,760
2024-07-15
PHATPhathom Pharmaceuticals, Inc.Henderson MollyCFO, CBOS - Sale$11.72-4,325101,358-4%-$50,689
2024-07-15
PHATPhathom Pharmaceuticals, Inc.Curran TerriePres, Chief ExecS - Sale$11.72-33,848381,574-8%-$396,699
M
2024-07-02
BIOEBio Essence CorpYan YinCEO, 10%S - Sale$8.03-60,27418,939,7260%-$484,286
D
2024-07-15
CDMOAvid Bioservices, Inc.Richieri Richard A.Chief Operations OfficerS - Sale+OE$8.36-53041,186-1%-$4,431
D
2024-07-15
CDMOAvid Bioservices, Inc.Kwietniak Matthew R.Chief Commercial OfficerS - Sale+OE$8.36-30723,410-1%-$2,567
M
2024-07-12
ELYMEliem Therapeutics, Inc.Morisset ValerieEVP, R, D, CSOS - Sale$7.04-92,377252,306-27%-$650,563
M
2024-07-12
ELVNEnliven Therapeutics, Inc.Patel AnishCOOS - Sale$25.06-50,000344,027-13%-$1,252,826
D
2024-07-12
ELVNEnliven Therapeutics, Inc.Hohl BenjaminCFOS - Sale+OE$25.07-3,0000-100%-$75,195
D
2024-07-15
CYTKCytokinetics IncParshall B LynneDirS - Sale+OE$55.82-5,00020,600-20%-$279,100
D
2024-07-15
NUVLNuvalent, Inc.Conley EmilyDirS - Sale+OE$80.72-5,0002,507-67%-$403,621
DM
2024-07-12
PEPGPepgen Inc.Mellion Michelle LChief Medical OfficerS - Sale+OE$18.02-9,1890-100%-$165,578
D
2024-07-12
NUVLNuvalent, Inc.Miller Deborah AnnGCS - Sale+OE$80.16-6,00033,300-15%-$480,960
M
2024-07-12
TRDAEntrada Therapeutics, Inc.Sethuraman NatarajanChief Scientific OfficerS - Sale$18.00-1,238188,814-1%-$22,284
M
2024-07-12
TRDAEntrada Therapeutics, Inc.Doshi DipalCEOS - Sale$17.84-1,900334,475-1%-$33,897
2024-07-16
ZVRAZevra Therapeutics, Inc.Anderson ThomasDirP - Purchase$6.81+10,00020,000+100%+$68,065
D
2024-07-12
RYTMRhythm Pharmaceuticals, Inc.Shulman JosephChief Technical OfficerS - Sale+OE$50.01-5,31330-99%-$265,725
2024-07-15
ETSTEarth Science Tech, Inc.Rose Christopher AlanCTOP - Purchase$0.22+22,50053,651+72%+$4,950
2024-07-12
LQDALiquidia CorpJeffs RogerCEOS - Sale$12.53-8,0532,407,1940%-$100,904
2024-07-12
LQDALiquidia CorpMoomaw ScottChief Commercial OfficerS - Sale$12.53-1,528151,682-1%-$19,146
D
2024-07-12
LQDALiquidia CorpAdair JasonChief Business OfficerS - Sale+OE$12.53-1,146115,226-1%-$14,359
2024-07-12
LQDALiquidia CorpSchundler RussellGCS - Sale$12.53-1,985500,1760%-$24,872
2024-07-12
LQDALiquidia CorpSaggar RajeevChief Medical OfficerS - Sale$12.53-1,470210,202-1%-$18,419
2024-07-12
LQDALiquidia CorpKaseta MichaelCFO, COOS - Sale$12.53-3,906312,389-1%-$48,942
DM
2024-07-11
ENTAEnanta Pharmaceuticals IncRottinghaus Scott T.Chief Medical OfficerS - Sale+OE$15.97-11,94521,717-35%-$190,747

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top